Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 1 Graft vs Host Disease 1 Bronchiolitis Obliterans Syndrome 1

Interventions

Nivolumab 10 Doxorubicin 10 Cyclophosphamide 10 Vinblastine 9 Radiotherapy 8 Dacarbazine 8 Brentuximab Vedotin 8 Bleomycin 7 fludarabine phosphate 6 fludarabine 6 Prednisone 6 Etoposide 6 pembrolizumab 5 Melphalan 5 Whole-Body Irradiation 4 Vincristine 4 Mycophenolic Acid 4 Filgrastim 4 Tacrolimus 3 Radiation 3 Prednisolone 3 Peripheral Blood Stem Cell Transplantation 3 Granulocyte Colony-Stimulating Factor 3 Busulfan 3 Thiotepa 2 Sirolimus 2 Procarbazine 2 Mechlorethamine 2 Bendamustine Hydrochloride 2 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Hodgkin Disease × axatilimab × Clear all

NCT05723055 2026-05-08

NAHL

University of Utah

Phase 2 Active not recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡